COPENHAGEN, DENMARK – April 1, 2013 – Today, Peder Holk Nielsen takes office as President & CEO of Novozymes.
New executive leadership team
The appointment of Peder Holk Nielsen as Novozymes’ new CEO was announced on January 21, 2013, in connection with the company’s full year earnings report.
- Average organic sales growth of more than 10% (from 2015 onward)
- EBIT margin of more than 24%
- Return on invested capital of more than 22%
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow’s industrial biosolutions, improving our customers’ business and the use of our planet’s resources. With over 700 products used in 130 countries, Novozymes’ bioinnovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s ever-changing marketplace. Read more at www.novozymes.com.